Acesso livre
Acesso livre

Psiquiatria

Estudo de coorte | Desfechos de longo prazo com o uso precoce de antipsicóticos injetáveis de ação prolongada na esquizofrenia.

19 Jun, 2022 | 13:10h

Long-term Outcomes of Early Use of Long-Acting Injectable Antipsychotics in Schizophrenia – The Journal of Clinical Psychiatry (link to abstract – $ for full-text)

Comentário: Patients With Schizophrenia Switched Early to LAIs Show Markedly Better Long-Term Outcomes – Psychiatric News Alert

Conteúdos relacionados:

Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis – The Lancet (link para o resumo – $ para o texto completo)

Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies – The Lancet Psychiatry (link para o resumo – $ para o texto completo)

Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies – The Lancet Psychiatry (link para o resumo – $ para o texto completo)

Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase Schizophrenia: A Randomized Clinical Trial – JAMA Psychiatry

Estudo de coorte de base populacional e controlado por irmão | Associação entre distúrbios relacionados ao estresse e risco subsequente de mortalidade por todas as causas e por causas específicas.

16 Jun, 2022 | 13:39h

Association of stress-related disorders with subsequent risk of all-cause and cause-specific mortality: A population-based and sibling-controlled cohort study – The Lancet Regional Health Europe

Conteúdos relacionados:

Mental Stress and Its Effects on Vascular Health – Mayo Clinic Proceedings

Association of the 2020 US Presidential Election With Hospitalizations for Acute Cardiovascular Conditions – JAMA Network Open

Psychological Stress and Heart Disease: Fact or Folklore? – The American Journal of Medicine

Sudden Cardiac Death Triggered by an Earthquake – New England Journal of Medicine

Cardiovascular Events during World Cup Soccer – New England Journal of Medicine

M-A | Prevalência de depressão entre cuidadores de pacientes oncológicos.

16 Jun, 2022 | 13:19h

Systematic Review and Meta-Analysis of Prevalence of Depression Among Caregivers of Cancer Patients – Frontiers in Psychiatry

Panorama global do impacto de sintomas depressivos/depressão maior em indivíduos vivendo com HIV/Aids e seus efeitos sobre a adesão aos medicamentos antirretrovirais.

16 Jun, 2022 | 13:18h

The Global Landscape of the Burden of Depressive Symptoms/Major Depression in Individuals Living With HIV/AIDs and Its Effect on Antiretroviral Medication Adherence: An Umbrella Review – Frontiers in Psychiatry

Revisão sistemática | Produtos feitos à base de Cannabis para dor crônica.

14 Jun, 2022 | 13:24h

Cannabis-Based Products for Chronic Pain: A Systematic Review – Annals of Internal Medicine

Resumo dos anais em vídeo: Cannabis-Based Products for Chronic Pain: A Systematic Review

Resumo para pacientes: Cannabis-Based Products for Chronic Pain

Conteúdos relacionados:

Podcast: #338 LIVE! Medical Cannabis: Is it still dope? – The Curbsiders

Medicinal Cannabis for Chronic Pain: The Bermuda Triangle of Low Quality Studies, Countless Meta-analyses and Conflicting Recommendations – European Journal of Pain

RCT: Effect of medical marijuana card ownership on pain, insomnia, and affective disorder symptoms in adults.

Cohort Study: Long-term cannabis use is associated with cognitive deficits and smaller hippocampal volume in midlife.

AHA Scientific Statement | How does cannabis use affect brain health? Caution advised, more research needed.

M-A: Birth outcomes of neonates exposed to marijuana in utero.

Cannabis-related allergies: an international overview and consensus recommendations.

Review: Cannabis-based medicines and medical cannabis for chronic neuropathic pain.

Cannabinoid metabolites as inhibitors of major hepatic CYP450 enzymes, with implications for cannabis-drug interactions.

Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain.

The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use.

Cannabis products are being sold as sleep remedies – here’s the evidence about their effectiveness.

Guideline: Medical cannabis or cannabinoids for chronic pain.

Cannabis and Cannabinoid Analgesia position statement – “Due to the lack of high-quality clinical evidence, the IASP does not currently endorse general use of cannabis and cannabinoids for pain relief.”

NICE Guideline: Cannabis-Based Medicinal Products

Consensus recommendations for perioperative management of cannabis and cannabinoid-based medicine users

Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain – Agency for Healthcare Research and Quality

Short Review: Drug Interactions with Cannabinoids

Meta-Analysis: Cannabinoids Not Effective for Cancer-Related Pain

Review: Considerations for cannabinoids in perioperative care by anesthesiologists.

Review: Cannabis-based Medicines and the Perioperative Physician

Study: Cannabis Use Disorder May Increase the Risk of Cardiovascular Events in Major Elective Surgeries

Perspective: If You Smoke Pot, Your Anesthesiologist Needs To Know

Perioperative Care of Cannabis Users: A Comprehensive Review of Pharmacological and Anesthetic Considerations

M-A | Como mudanças de renda impactam a saúde mental e o bem-estar de adultos em idade de trabalho?

14 Jun, 2022 | 13:05h

How do income changes impact on mental health and wellbeing for working-age adults? A systematic review and meta-analysis – The Lancet Public Health – The Lancet Public Health

Comentário convidado: The impact of income on mental health

 

Comentário da autora no Twitter (fio – clique para saber mais)

 

M-A | A prevalência de sérias comorbidades de doenças mentais e transtornos do uso de substâncias em populações prisionais.

14 Jun, 2022 | 13:04h

The prevalence of comorbid serious mental illnesses and substance use disorders in prison populations: a systematic review and meta-analysis – The Lancet Public Health

Comentário convidado: The prevalence of comorbid substance use disorders and serious mental illnesses in prisons

Revisão sistemática e metanálise de 208 estudos randomizados controlados | Eficácia da neuroestimulação nos transtornos mentais.

13 Jun, 2022 | 14:26h

Efficacy of neurostimulation across mental disorders: systematic review and meta-analysis of 208 randomized controlled trials – Molecular Psychiatry

Estudo randomizado | Eficácia, segurança e tolerabilidade da centanafadina em comprimidos de liberação prolongada em adultos com transtorno de déficit de atenção/hiperatividade.

13 Jun, 2022 | 14:02h

Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder: Results of 2 Phase 3, Randomized, Double-blind, Multicenter, Placebo-Controlled Trials – Journal of Clinical Psychopharmacology

Diretriz de política AAP | Terminologia recomendada para transtorno de uso de substâncias na atenção a crianças, adolescentes, jovens adultos e familiares.

6 Jun, 2022 | 11:25h

Recommended Terminology for Substance Use Disorders in the Care of Children, Adolescents, Young Adults, and Families – Pediatrics

 

Comentário de um dos autores no Twitter (fio – clique para saber mais)

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.